Galinis

Galinis v. Bayer Corporation

Good Law
United States District Court, Northern District of CaliforniaJanuary 22, 20203:09-cv-04980California2,055 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 SUSAN GALINIS, et al., Case No. 09-cv-04980-SI

Plaintiffs,

ORDER GRANTING IN PART AND

v. DENYING IN PART MOTION RE

COMMON BENEFIT ASSESSMENT

BAYER CORPORATION, et al., Re: Dkt. Nos. 174, 179, 186 Defendants.

12 This action is before the Court upon remand from the Southern District of Illinois, where the Honorable David R. Herndon oversaw the multi-district litigation (“MDL”) In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, No. 09-md-02100- DRH-PMF. Because this case was an outlier in many respects, Judge Herndon recommended remand to this Court on October 1, 2018; the JPML agreed, and on December 28, 2018 this case was remanded to this District. Dkt. No. 75, 79. In October 2019, after being sent back to this Court, plaintiffs Susan Galinis and Richard Galinis1 and defendant Bayer HealthCare Pharmaceuticals Inc. (“Bayer”) reached an agreement in principle resolving all matters in…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.